Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
Clinical trial NCT06425926 · RECRUITING
Trial details
- NCT number
- NCT06425926
- Sponsor
- Georgiamune Inc
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-09
- Primary completion
- 2026-12-01
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.